↓ Skip to main content

Clinical and regulatory perspectives on biosimilar therapies and intended copies of biologics in rheumatology

Overview of attention for article published in Rheumatology International, February 2016
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (56th percentile)
  • Above-average Attention Score compared to outputs of the same age and source (59th percentile)

Mentioned by

twitter
4 X users

Citations

dimensions_citation
62 Dimensions

Readers on

mendeley
113 Mendeley